| Hemlata Daryani, | |
|
14 Temple St, Apartment #4f, Framingham, MA 01702-2405 | |
| (508) 309-4939 | |
| Not Available |
| Full Name | Hemlata Daryani |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 14 Temple St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679532691 | NPI | - | NPPES |
| 4754311 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301076504 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth's Medical Center | Brighton, MA | Hospital |
| Good Samaritan Medical Center | Brockton, MA | Hospital |
| Saint Anne's Hospital | Fall river, MA | Hospital |
| Morton Hospital | Taunton, MA | Hospital |
| Holy Family Hospital | Methuen, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating that VB-201 possesses anti-inflammatory properties and effectively reduced the symptoms of arthritis in experimental models.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
In 2013 Ob Hospitalist Group launched the Founder's Award Program; a recognition program designed to honor those employees who embrace OBHG's core values, contribute to our vision of elevating the standard of women's healthcare, and share OBHG founder, Dr. Chris Swain's vision that every expectant mother receives timely, consistent, unconditional, quality medical care by a physician when presenting to the Labor and Delivery Unit. Proudly we announce the first of these awards: the 2013 Physician of the Year, and the recipient, Dr. Dalibor Hradek.
› Verified 6 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356654495 PECOS PAC ID: 2860688728 Enrollment ID: O20101120000012 |
News Archive
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating that VB-201 possesses anti-inflammatory properties and effectively reduced the symptoms of arthritis in experimental models.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
In 2013 Ob Hospitalist Group launched the Founder's Award Program; a recognition program designed to honor those employees who embrace OBHG's core values, contribute to our vision of elevating the standard of women's healthcare, and share OBHG founder, Dr. Chris Swain's vision that every expectant mother receives timely, consistent, unconditional, quality medical care by a physician when presenting to the Labor and Delivery Unit. Proudly we announce the first of these awards: the 2013 Physician of the Year, and the recipient, Dr. Dalibor Hradek.
› Verified 6 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821349317 PECOS PAC ID: 2860688728 Enrollment ID: O20130626000396 |
News Archive
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating that VB-201 possesses anti-inflammatory properties and effectively reduced the symptoms of arthritis in experimental models.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
In 2013 Ob Hospitalist Group launched the Founder's Award Program; a recognition program designed to honor those employees who embrace OBHG's core values, contribute to our vision of elevating the standard of women's healthcare, and share OBHG founder, Dr. Chris Swain's vision that every expectant mother receives timely, consistent, unconditional, quality medical care by a physician when presenting to the Labor and Delivery Unit. Proudly we announce the first of these awards: the 2013 Physician of the Year, and the recipient, Dr. Dalibor Hradek.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hemlata Daryani, 14 Temple St, Apartment #4f, Framingham, MA 01702-2405 Ph: () - | Hemlata Daryani, 14 Temple St, Apartment #4f, Framingham, MA 01702-2405 Ph: (508) 309-4939 |
News Archive
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating that VB-201 possesses anti-inflammatory properties and effectively reduced the symptoms of arthritis in experimental models.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
In 2013 Ob Hospitalist Group launched the Founder's Award Program; a recognition program designed to honor those employees who embrace OBHG's core values, contribute to our vision of elevating the standard of women's healthcare, and share OBHG founder, Dr. Chris Swain's vision that every expectant mother receives timely, consistent, unconditional, quality medical care by a physician when presenting to the Labor and Delivery Unit. Proudly we announce the first of these awards: the 2013 Physician of the Year, and the recipient, Dr. Dalibor Hradek.
› Verified 6 days ago
Dr. Ronald J Bick, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Metrowest Medical Center, Framingham, MA 01702 Phone: 508-383-1300 | |
Mary Lou Morris, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1335 | |
Dr. Daniel William O'connell, DO Radiology Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Dr. Muhammad Hammad Malik, MBBS, MD Radiology Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Muhammad Omar Afridi, DO Radiology Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Dr. Amogh Srivastava, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1300 | |
Michelle N Swire, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 571 Union Ave Ste 101, Framingham, MA 01702 Phone: 508-848-2164 Fax: 978-320-7024 |